Latest News
- Psoriasis
Thursday, March 21, 2019
Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasis
Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration …
Read the full storyWednesday, March 20, 2019
Are Skin Diseases More Common Than Previously Held?
Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases…
Read the full storyMonday, March 11, 2019
Calling All Students: Ortho Dermatologics Now Accepting Applications for the 2019 Aspire Higher Scholarship Program
Ortho Dermatologics is accepting applications for its 2019 Aspire Higher scholarship program, which will award $90,000 total in scholarships to nine students who have been treated for a dermatologic c…
Read the full storyTuesday, March 05, 2019
Get to Know the Dermatology Hall of Fame's 2019 Inaugural Class of Inductees
The 10 individuals inducted into the Dermatology Hall of Fame’s 2019 Inaugural Class are: Albert Bernard Ackerman, M.D., the author of “Histologic Diagnosis of Inflammatory Skin Disease…
Read the full storySaturday, March 02, 2019
Bimekizumab Provides Long-Term Skin Clearance for Psoriasis Patients in Phase 2b Study
UCB’s bimekizumab demonstrated long-term maintenance of complete or almost complete skin disease resolution for psoriasis patients, according to results from the Phase 2b BE ABLE 2 Extension Stu…
Read the full story
Friday, March 01, 2019
Floodwaters and Climate Change Increase Risks for Dermatologic Disease
As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, both disaster victims and relief workers have experienced significant dermatologic …
Read the full story
Wednesday, February 27, 2019
FDA Approves Janssen's Tremfya One-Press
The FDA has approved Tremfya® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-severe plaque psoriasis. Tremfya®(guselkumab) from the Janssen Pharmaceutic…
Read the full storyWednesday, February 13, 2019
Two New Psoriasis Guidelines Address Comorbidities, Biologic Treatment
The American Academy of Dermatology and the National Psoriasis Foundation have released two new guidelines outlining best practices for treating psoriasis with a focus on comorbidities and biologic tr…
Read the full story
Tuesday, February 05, 2019
Biologics May Reduce Plaque Buildup in Psoriasis Patients’ Arteries
Treating psoriasis with biologic drugs can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke, according to a study funded by the National…
Read the full storyFriday, February 01, 2019
Menlo Therapeutics to Present Late-Breaking Oral Presentation at AAD Annual Meeting
Menlo Therapeutics Inc., a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus, has had its abstract accepted for oral presentation at the Late…
Read the full storyThursday, January 31, 2019
Encore Dermatology Shares Positive Pivotal Study Results for Impoyz for the Treatment of Plaque Psoriasis
Impoyz Cream (clobetasol propionate) Cream, 0.025% demonstrated efficacy early with 14.2 percent of Impoyz patients achieving treatment success at day 8 versus 1.6 percent in the vehicle group, accord…
Read the full storyMonday, January 28, 2019
New Data Show Cosentyx Improves Quality of Life in Patients Being Treated for Psoriasis
Novartis shared results from a pooled analysis of four Phase 3 clinical trials demonstrating patients with moderate to severe plaque psoriasis (PsO) treated with Cosentyx (secukinumab) 300mg reported …
Read the full story
Wednesday, January 23, 2019
Alan Menter, MD Receives Outstanding Researcher and Educator in Psoriatic Disease Award from ODAC, JDD
Alan Menter, MD, has been awarded the Outstanding Researcher and Educator in Psoriatic Disease Award by the ODAC Dermatology, Aesthetics & Surgical Conference, in partnership with the Journal…
Read the full story
Thursday, January 03, 2019
Bristol-Myers Squibb to Acquire Celgene
Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …
Read the full story
Tuesday, December 11, 2018
Dermatologists Need More Info About Cannabinoids
Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new survey in Journal of Drugs in Dermatology. However, many are concerned a…
Read the full story
